Nilesh Wadhwa has stepped down as Head – Formulation Business Development at Alembic Pharmaceuticals, with his resignation taking effect after the close of business on 31 March 2026. The company announced the change in management in a formal note to the exchanges, underscoring a leadership shift within its formulation and business development apparatus.